New research suggests blocking part of a DNA repair complex that helps some types of leukemia resist treatment can increase the effectiveness of chemotherapy and enhance survival. Scientists report that their experimental combination treatment strategy — using a small molecular inhibitor along with chemotherapy — was particularly effective at stopping a stubborn leukemia called T-cell acute lymphoblastic leukemia.